⌘K

Home/Filings/4/0001062993-22-017457

4//SEC Filing

KISHORE GANESH 4

Accession 0001062993-22-017457

CIK 0001822691other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 10:21 AM ET

Size

5.4 KB

Accession

0001062993-22-017457

Insider Transaction Report

Form 4

Period: 2022-05-10

GreenLight Biosciences Holdings, PBCGRNA

Director

Transactions

Award
Stock Option (Right to Buy)
2022-05-10+65,000→ 65,000 total
Exercise: $7.96Exp: 2032-05-10→ Common Stock (65,000 underlying)

Footnotes (1)

[F1]25,000 shares underlying the option vested or shall vest in four equal quarterly installments, the first of which shall vest on May 3, 2022. The remaining 40,000 shares underlying the option vested or shall vest in twelve equal quarterly installments, the first of which shall vest on May 3, 2022.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

GreenLight Biosciences Holdings, PBC

CIK 0001822691

Entity typeother

Related Parties

1

filerCIK 0001083218

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 10:21 AM ET
Size: 5.4 KB

View on SEC.gov